Bridging clinical and basic science
towards the cure of cancer
To promote the development of scientific research into pioneering clinical practice, thus enabling our patients to benefit from the very latest advances in oncological research
The database contains 117 publications. These include publications both with and without an impact factor.
TOTAL IF 2008: 715.467
Translational Research allows the development of personalized treatment for cancer
Today, we know much more about why a cell becomes cancerous and about which proteins and genes are responsible for this happening
VHIO tests a new combination of drugs for HER2-positive breast cancer without the adverse effects of conventional chemotherapy
This research studied the action mechanisms of two drugs—lapatinib and trastuzumab—in combination for the treatment of HER2-positive breast cancer. Lapatinib is a molecule which, when combined with trastuzumab, neutralizes the activity of the HER2 receptor and improves the effect of the antibody
©2008 VALL D’HEBRON. Institut d’Oncologia. Todos los derechos reservados